Jiamin Cao

416 total citations
35 papers, 251 citations indexed

About

Jiamin Cao is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jiamin Cao has authored 35 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jiamin Cao's work include Ophthalmology and Eye Disorders (11 papers), Glaucoma and retinal disorders (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Jiamin Cao is often cited by papers focused on Ophthalmology and Eye Disorders (11 papers), Glaucoma and retinal disorders (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Jiamin Cao collaborates with scholars based in China and Hong Kong. Jiamin Cao's co-authors include Wei Xiong, Xin Qi, Nuo Wang, Chen Ma, Gcf Chan, Chen Ma, Xianying Fang, Xin Qi, Feng Zhang and Wei Xiong and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Jiamin Cao

26 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiamin Cao China 10 99 70 51 29 26 35 251
Anna Popławska‐Kita Poland 11 87 0.9× 38 0.5× 198 3.9× 66 2.3× 34 1.3× 49 396
Shiqian Hu China 7 44 0.4× 79 1.1× 145 2.8× 28 1.0× 64 2.5× 7 280
Kaida Mu China 10 89 0.9× 30 0.4× 126 2.5× 53 1.8× 86 3.3× 22 306
Szymon Zmorzyński Poland 9 119 1.2× 33 0.5× 8 0.2× 27 0.9× 33 1.3× 39 277
Sharifeh Khosravi Iran 11 130 1.3× 19 0.3× 23 0.5× 13 0.4× 38 1.5× 19 303
Katarzyna Oszajca Poland 11 154 1.6× 16 0.2× 11 0.2× 19 0.7× 25 1.0× 24 339
Maria Salomè Bezerra Espinola Italy 10 283 2.9× 17 0.2× 51 1.0× 20 0.7× 23 0.9× 16 486
Shunji Shiohira Japan 8 125 1.3× 59 0.8× 13 0.3× 88 3.0× 24 0.9× 19 361
Dominika Łacheta Poland 5 66 0.7× 74 1.1× 56 1.1× 13 0.4× 69 2.7× 8 279
Caojian Zuo China 8 117 1.2× 96 1.4× 16 0.3× 24 0.8× 79 3.0× 10 371

Countries citing papers authored by Jiamin Cao

Since Specialization
Citations

This map shows the geographic impact of Jiamin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiamin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiamin Cao more than expected).

Fields of papers citing papers by Jiamin Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiamin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiamin Cao. The network helps show where Jiamin Cao may publish in the future.

Co-authorship network of co-authors of Jiamin Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiamin Cao. A scholar is included among the top collaborators of Jiamin Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiamin Cao. Jiamin Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Wei‐Cai, Mengjia Sun, Jiamin Cao, et al.. (2025). Triterpenoids from ilicis rotundae cortex ameliorate hyperlipidemia by affecting bile acids-hepatointestinal FXR axis. Phytomedicine. 139. 156537–156537. 3 indexed citations
2.
Wang, Haisheng, et al.. (2025). Quality and content evaluation of thyroid eye disease treatment information on TikTok and Bilibili. Scientific Reports. 15(1). 25134–25134. 6 indexed citations
3.
Ouyang, Pingbo, Qi Jia, Yun Li, et al.. (2025). Butyrate Ameliorates Graves’ Orbitopathy Through Regulating Orbital Fibroblast Phenotypes and Gut Microbiota. Investigative Ophthalmology & Visual Science. 66(3). 5–5. 4 indexed citations
4.
Cao, Jiamin, Liping Zhu, Wei‐Cai Zeng, et al.. (2025). Endophytic fungus MH397503 mediates the structural modification of agarwood chromones and its anti-vascular endothelial injury activity. Fitoterapia. 187. 106872–106872.
5.
6.
7.
Chen, Haiyan, et al.. (2025). Sleep quality and its determinants in patients with thyroid eye disease: a cross-sectional study. European journal of medical research. 30(1). 446–446.
8.
Yu, Cong, et al.. (2025). A bibliometric and visual analysis of Jak1 to explore trends and frontiers. Frontiers in Oncology. 15. 1537508–1537508.
9.
Zhang, Feng, et al.. (2025). Role of cGAS-STING pathway in fibrotic disease. Pharmacological Research. 221. 107971–107971. 1 indexed citations
10.
Cao, Jiamin, et al.. (2023). Gentiopicroside inhibits retinoblastoma cell proliferation, invasion, and tumorigenesis in nude mice by suppressing the PI3K/AKT pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(2). 1003–1013. 2 indexed citations
11.
Cao, Jiamin, et al.. (2023). Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study. Journal of the Endocrine Society. 8(1). 2 indexed citations
12.
13.
Cao, Jiamin, Feng Zhang, & Wei Xiong. (2023). Discovery of Aptamers and the Acceleration of the Development of Targeting Research in Ophthalmology. International Journal of Nanomedicine. Volume 18. 4421–4430. 12 indexed citations
14.
15.
Cao, Jiamin, et al.. (2023). Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves’ orbitopathy. Journal of Endocrinological Investigation. 46(10). 2005–2016. 2 indexed citations
16.
Xiong, Wei, Feng Zhang, Nuo Wang, et al.. (2022). The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease. Molecular and Cellular Endocrinology. 559. 111780–111780. 10 indexed citations
17.
Qi, Xin, et al.. (2022). Botox-A improve the thyroid-associated ophthalmopathy (TAO) orbital fibroblast activation through inhibiting the TGF-β/Smad signaling. Experimental Eye Research. 217. 108971–108971. 3 indexed citations
18.
Cao, Jiamin, et al.. (2021). The risk factors for Graves’ ophthalmopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(4). 1043–1054. 28 indexed citations
19.
Cao, Jiamin, et al.. (2021). Epigenetics effect on pathogenesis of thyroid-associated ophthalmopathy. International Journal of Ophthalmology. 14(9). 1441–1448. 14 indexed citations
20.
Liu, Yin Ping, et al.. (2015). Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models. Experimental Hematology and Oncology. 4(1). 13–13. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Popławska‐Kita Breakdown of academic impact, for papers by Shiqian Hu Breakdown of academic impact, for papers by Kaida Mu Breakdown of academic impact, for papers by Szymon Zmorzyński Breakdown of academic impact, for papers by Sharifeh Khosravi Breakdown of academic impact, for papers by Katarzyna Oszajca Breakdown of academic impact, for papers by Maria Salomè Bezerra Espinola Breakdown of academic impact, for papers by Shunji Shiohira Breakdown of academic impact, for papers by Dominika Łacheta Breakdown of academic impact, for papers by Caojian Zuo
Rankless by CCL
2026